Latest TGA News

TGA Product Information Safety Updates 20 July
Unapproved peptide product promoters and suppliers are put on notice
New Regulations Strengthen Controls On Nicotine Pouches
New information relating to s 9D(1) applications for listed medicines
TGA leads crackdown of illegal nicotine products across Darwin
Monash University joins TGA Academic Outreach Program
TGA Acts On Melatonin Imports
There’s one reason why so many cold and flu tablets don’t actually work
Canngea Pty Ltd issued infringement notices totalling $59,400 for alleged failure to comply with a request for information about the supply of…
Take control of your learning journey and understand your regulatory obligations
Withania Somnifera And Very Rare Risk Of Liver Injury
Darolutamide (Nubeqa) – Hope for men with high-risk non-metastatic hormone resistant prostate cancer
TGA issues infringement notices to nurse for alleged unlawful importation of cosmetic injectables
New UDI requirements for medical devices commence 1 July 2026
Listed Medicine Compliance Reports – June 2026 Update
Delays In Care Present Greatest Risk To Patients
MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next
Under-qualified prescribing of controlled medicines poses risk to public health
Operation TEMPEST sweeps VIC and TAS in major illicit tobacco and vaping crackdown
Concerns regarding the public health risks associated with unapproved peptide products
Update To Listed Medicine Ingredients In June 2026
TGA releases new guidance on advertising restrictions for prescription medicines
TGA issues infringement notices to a health professional and an individual for alleged unlawful importation of cosmetic injectables
TGA Product Information Safety Updates 15 June
What to know if you’ve been prescribed medicinal cannabis
Do your patients know the risks of unapproved medicinal cannabis products?
Landmark approval of Tzield in Australia ushers in a new era of delay for type 1 diabetes
Updates to Authorised Prescriber (AP) scheme requirements when accessing MDMA and psilocybine
Health practitioners – how to access medicines during a national shortage
Individual issued 27 infringement notices for allegedly supplying Melanotan II
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal
Updates To Prescribing Medicines In Pregnancy Database 19 May
Unlawful Therapeutic Goods Seized In Global Operation
Forging an integrative health research alliance with India
Tranexamic acid: risk of serious adverse events after inadvertent spinal administration
New TGA guidance clarifies requirements for compounded medicines
Indonesia: New halal certification requirements for medicines and medical devices
Higher-strength medicinal cannabis may be linked to a disturbing pattern of side effects, our study shows
Efficacy Of Listed Medicines For Exercise Performance
Can’t get your HRT patches? What to do and what to avoid
Updates to the List of Australian Manufacturers Licensed by the TGA
New research raises concerns about safety of higher-THC medicinal cannabis products in Australia
NSW And ACT Target For Illicit Tobacco Strike
TGA issues infringement notices for alleged unlawful advertising of therapeutic goods involving prohibited representations
Veganic SKN directed to cease supply and relabel or destroy unapproved sunscreens
Enforceable Direction: Veganic SKN Limited
AFP confiscates more than $1 million linked to illicit vape sales
Inclusive assessments allow more Canberrans to donate blood